Roche lays out access ambitions in its ESG strategies, including innovation and value goals
Roche laid out its ambitions in the social part of its environmental, social and governance (ESG) strategy on Monday centered on access to its drugs and diagnostics.
The Roche inaugural Access to Healthcare investor call follows a general pharma industry trend in ESG. More companies are publishing reports and holding calls to outline climate, societal, diversity, and even pricing goals as investors clamor for details amid surging interest in ESG commitments.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.